Introduction
Legitimate demands for a sophisticated quality management in medicine—by authorities,
scientific organizations, health care companies, and patients all over the world—have
stimulated a quality awareness resulting in the development of versatile quality assurance
activities such as benchmark projects, registries, and others to answer those needs.
As early as 1978, the board of directors of the German Society for Thoracic and Cardiovascular
Surgery (GSTCVS, www.dgthg.de) decided to set up an annually updated data collection of all cardiac surgical procedures
in terms of a voluntary registry. Since 1989, the data are annually updated, summarized
in registry format, and published in the scientific journal of the GSTCVS.[1]
[2]
[3]
[4]
[5]
[6]
[7]
[8]
[9]
[10]
[11]
[12]
[13]
[14]
[15]
[16]
[17]
[18]
[19]
[20]
[21]
[22]
[23]
[24]
[25]
[26]
[27] The aims of this registry are to gather developments and upcoming trends in cardiac
surgery in Germany; to compile various results for nearly all cardiac surgical procedures;
to enable each participant a comparison of the reached individual institutional results
to the nationwide achievements; and to facilitate an evaluation on an international
level for the German society.
For monitoring actual conditions as well as developments in cardiac medicine, the
registry covers all relevant techniques and also innovative technologies including
minimally invasive cardiac surgery and all kinds of heart valve operations including
transcatheter heart valve interventions (e.g. TAVI). Thereby, important findings for
current patient safety and the future of patient care are collected and can be evaluated
under different aspects.
Data and results presented in this report comprehend assorted data of the year 2016.
Materials and Methods
Since 2004, a standardized questionnaire gathers specific information for well-defined
procedures exactly described by an annually updated German adaption of the International
Classification of Procedures in Medicine called operation code (Operationen- und Prozedurenschlüssel).
All participating institutions were requested to complete the structured questionnaire
by January 22, 2017, entering all performed procedures and associated in-hospital
mortality. The recommended path for data export is an electronic transmission of an
encrypted file to the office of the GSTCVS in Berlin. After transaction, the data
are decrypted, evaluated for completeness, and compiled for further analysis, thus
ensuring anonymity for each participating institution. This compilation algorithm
guarantees a high compliance for submission of complete datasets.
Inclusion criteria for the registry 2016 were all cardiac surgical procedures performed
on patients between January 1, 2016, and December 31, 2016, unrelated to the date
of admission or discharge of the patients as compared with other registries. Like
in the earlier years, the number of procedures was counted rather than individual
patients. For example, if during one admission a patient initially required isolated
mitral valve reconstruction later followed by a coronary artery bypass grafting (CABG)
due to an undesirable event, one count in the category “mitral valve reconstruction”
and a second one in the category “coronary surgery” are enumerated. Thus, the registry
contains more procedures than the real number of patients operated on.
Death of patients was defined as in-hospital mortality. Per definition, the observed
mortality is always attributed to the first cardiac procedure, e.g. patient mortality
will be attributed to an initial CABG procedure even if in a second procedure a replacement
of the ascending aorta is performed due to a complication of the first operation.
In case of fixing an undesirable event during the initial procedure, mortality will
be counted under the more complex part of the operation.
The main reason for this structural setup of the registry—established over several
decades—is to keep in accordance with the German data privacy act with its specific
regulations for patients. Furthermore, it seemed to be relevant to get detailed information
about all performed procedures and not only the number of treated patients. Last but
not least, the process of data acquisition had to be standardized and feasible for
all participants in Germany, thus enabling the submission of a complete dataset, regardless
of the locally existing hardware and software used for data acquisition.
In 2016, a total of 78 institutions performed heart surgery. Fortunately, all departments
answered the questionnaire and delivered a complete dataset for the year 2016 including
hospital mortality rates.
Registry Data 2016
[Table 1] gives an overview of cardiac surgical procedures by distribution between the 16
German states, based on the population count of the Federal Office for Statistics
as of December 31, 2014. In this table, the range of heart operations per 100,000
inhabitants shows a minimum of 105.9 (Baden Württemberg) and a maximum of 168.8 (Sachsen-Anhalt),
resulting in a nationwide mean value of 125.7 (2015: 126.6). Analyzing the heart operations
by department dimension, 56% performed between 519 and 1,363 procedures ([Table 2]). Summarizing the departments by various heart surgical procedures, it can be determined
that heart operations in patients for congenital heart disease (< 1 year, with extracorporeal
circulation [ECC]) are conducted in 21 institutions and heart transplantations in
22 institutions ([Table 3]), in near accordance to the previous year. [Table 4] illustrates the number of procedures using ECC from 2007 to 2016 in Germany. Over
the past decade, the number of heart operations using ECC shows a diminution by 12,536
procedures, certainly an achievement of established innovations and minimally invasive
therapies in heart surgery.
Table 1
Heart operations/German states
German states
|
Quantity[a]
|
Population[b]
|
Heart procedures/100,000 inhabitants
|
Baden Württemberg
|
11,348
|
10,716,644
|
105.9
|
Bayern
|
14,159
|
12,691,568
|
111.6
|
Berlin
|
3,897
|
3,469,849
|
112.3
|
Brandenburg
|
3,332
|
2,457,872
|
135.6
|
Bremen
|
875
|
661,888
|
132.2
|
Hamburg
|
2,387
|
1,762,791
|
135.4
|
Hessen
|
7,599
|
6,093,888
|
124.7
|
Mecklenburg-Vorpommern
|
1,926
|
1,599,138
|
120.4
|
Niedersachsen
|
10,734
|
7,826,739
|
137.1
|
Nordrhein-Westfalen
|
23,134
|
17,638,098
|
131.2
|
Rheinland-Pfalz
|
5,360
|
4,011,582
|
133.6
|
Saarland
|
1,471
|
989,035
|
148.7
|
Sachsen
|
5,070
|
4,055,274
|
125.0
|
Sachsen-Anhalt
|
3,773
|
2,235,548
|
168.8
|
Schleswig-Holstein
|
4,078
|
2,830,864
|
144.1
|
Thüringen
|
2,945
|
2,156,759
|
136.5
|
Deutschland
|
102,088
|
81,197,537
|
125.7
|
a 1,018 foreign residents excluded.
b Federal Office for Statistics of Germany: Population; due date December 31, 2014.
Table 2
Units assorted by quantified categories (∑[a] [n = 103,128])
Procedures (quantity)
|
<500
|
500–999
|
1,000–1,499
|
1,500–1,999
|
2,000–5,000
|
Departments (number)
|
8
|
21
|
23
|
13
|
13
|
Average
|
387
|
817
|
1,156
|
1,698
|
2,632
|
Range
|
216–490
|
519–996
|
1,019–1,363
|
1,517–1,926
|
2,008–3,939
|
a Pacemaker/implantable cardioverter defibrillator and extracardiac surgery without
ECC excluded.
Table 3
Departments summarized by heart surgery procedures 2016
Type of surgery performed
|
N
|
Coronary artery bypass grafting
|
77
|
Heart valve surgery
|
77
|
Surgery for CHD in pts <1 y with ECC
|
21[a]
|
HTx
|
22[b]
|
HLTx
|
4
|
Abbreviations: CHD, congenital heart disease; ECC, extracorporeal circulation; HTx,
heart transplantation; HLTx, heart–lung transplantation; pts, patients; Tx, transplantation.
a
N = 2,130: thereof: 15 to 19 procedures in 3 units, 30 to 49 procedures in 4 units,
57 to 94 procedures in 4 units, and 100 to 274 procedures in 10 units.
b
N = 291: thereof: 1 to 3 Tx in four units, 5 to 9 Tx in eight units, 10 to 19 Tx in
eight units, and 23 to 82 Tx in two units.
Table 4
Cardiac procedures using extracorporeal circulation (2007–2016)
|
2007
|
2008
|
2009
|
2010
|
2011
|
2012
|
2013
|
2014
|
2015
|
2016
|
Units
|
80
|
79
|
80
|
79
|
78
|
79
|
79
|
78
|
78
|
78
|
Operations
|
91,618
|
89,773
|
86,916
|
84,686
|
84,402
|
84,388
|
84,040
|
83,787
|
81,527
|
79,082
|
Average
|
1,145
|
1,136
|
1,086
|
1,072
|
1,082
|
1,068
|
1,064
|
1,074
|
1,045
|
1,014
|
Overall, 184,789 procedures were reported to the registry for the year 2016 ([Table 5]), a decrease of 0.3% (2015: 185,270 procedures). A total of 103,128 heart surgical
procedures (excluded: implantable cardioverter defibrillator, pacemakers, and miscellaneous
procedures without ECC) in 2016 display a comparable quantity with a difference of
0.8% (n = 839) compared with 2015 (103,967 procedures) [Tables 6], [7], [V1]
[V2]
[V3]
[V4]
[V5]
[V6]
[V7], [C1], [C2], [Con1], [Con2], and [Mis1]
[Mis2]
[Mis3]
[Mis4]
[Mis5] and [Figs. 1]
[2]
[3]
[4]
[5]
[6]
[7]
[8]
[9] demonstrate various compiled registry data concerning 2016 under different aspects
and for various categories.
Table 5
Frequency of cardiac procedures 2016
Category
|
With ECC
|
Without ECC
|
Total
|
Difference 2015 (%)
|
Coronary artery bypass grafting
|
42,813*
|
7,301*
|
50,114
|
−3.5
|
Heart valve procedures
|
21,877*
|
11,574*
|
33,451
|
+3.4
|
Surgery of thoracic aorta
|
7,369*
|
750*
|
8,119
|
+2.5
|
Surgery for CHD
|
4,762*
|
1,093*
|
5,855
|
−0.6
|
Cardiac surgery, other
|
1,072*
|
1,183*
|
2,255
|
−5.2
|
Assist device procedures**
|
789*
|
2,145*
|
2,934
|
−4.6
|
Extracardiac surgery
|
358*
|
57,023
|
57,381
|
+4.1
|
Pacemaker and ICD procedures
|
42*
|
24,638
|
24,680
|
−7.1
|
Total
|
79,082
|
105,707
|
184,789
|
−0.3
|
*Sum: n = 103,128 (heart surgery procedures).
**Sum: VADs/TAH/others devises (e.g. ECLS/ECMO).
Abbreviations: CHD, congenital heart disease; ECC, extracorporeal circulation; ICD,
implantable cardioverter defibrillator; VADs; Ventricular assist devices; TAH, total
artificial heart; ECLS, Extracoporeal life support; ECMO, Extracorporeal membrane
oxygenation.
Table 6
Additional data for heart procedures with ECC in 2016 versus 2015
Procedures
|
2016
|
2015
|
Emergency
|
12,745
|
12.4%
|
12,843
|
12.4%
|
Redo
|
9,186
|
8.9%
|
8,994
|
8.7%
|
Abbreviation: ECC, extracorporeal circulation.
Table 7
Gender distribution
|
Female (%)
|
Male (%)
|
Heart valve procedures
|
43
|
57
|
Coronary procedures
|
23
|
77
|
Surgery for CHD
|
45
|
55
|
Surgery of thoracic aorta
|
34
|
66
|
Cardiac surgery, other
|
57
|
43
|
Assist devices
|
26
|
74
|
Pacemaker and ICD
|
36
|
64
|
Extracardiac surgery
|
35
|
65
|
Total
|
34
|
66
|
Abbreviations: CHD, congenital heart disease; ICD, implantable cardioverter defibrillator.
Table V1
Isolated valve procedures
Procedures
|
N
|
†
|
%
|
Single
|
17,855
|
680
|
3.8
|
Double
|
3,298
|
323
|
9.8
|
Triple
|
409
|
59
|
14.4
|
Transcatheter access (single valve)
|
11,701
|
363
|
3.1
|
Transcatheter access (double valve)
|
15
|
2
|
13.3
|
Not specified
|
173
|
9
|
5.2
|
Total
|
33,451
|
1,436
|
4.3
|
Note: Transcatheter valve procedures: 10,879 aortic valve implantations; 147 mitral valve
implantations; 650 mitral valve repairs; 2 tricuspid valve implantations; 23 tricuspid
valve repairs; 15 double aortic and mitral valve procedures; no pulmonary valve implantation.
Table V2
Single heart valve procedures: access type
Heart valve/access
|
N
|
†
|
%
|
Aortic valve
|
21,963
|
680
|
3.1
|
Sternotomy
|
7,879
|
310
|
3.9
|
Partial sternotomy
|
3,205
|
45
|
1.4
|
Transvascular
|
8,792
|
231
|
2.6
|
Transapical
|
2,087
|
94
|
4.5
|
Mitral valve
|
7,014
|
303
|
4.3
|
Sternotomy
|
3,115
|
214
|
6.9
|
Minimal invasive
|
3,102
|
52
|
1.7
|
Transcatheter
|
797
|
37
|
4.6
|
Tricuspid valve
|
531
|
58
|
10.9
|
Sternotomy
|
381
|
47
|
12.3
|
Minimal invasive
|
125
|
10
|
8.0
|
Transcatheter
|
25
|
1
|
4.0
|
Pulmonary valve
|
48
|
2
|
4.2
|
Sternotomy
|
48
|
2
|
4.2
|
Minimal invasive
|
0
|
0
|
–
|
Transcatheter
|
0
|
0
|
–
|
Total
|
29,556
|
1,043
|
3.5
|
Table V3
Isolated aortic valve procedures
Prosthesis/native valve
|
N
|
†
|
%
|
Xenograft
|
9,722
|
322
|
3.3
|
Mechanical prosthesis
|
1,201
|
28
|
2.3
|
Repair
|
123
|
2
|
1.6
|
Homograft
|
38
|
3
|
7.9
|
Total
|
11,084
|
355
|
3.2
|
Table V4
Isolated mitral valve procedures
Prosthesis/native valve
|
N
|
†
|
%
|
Repair
|
3,908
|
49
|
1.3
|
Xenograft
|
1,821
|
190
|
10.4
|
Mechanical prosthesis
|
473
|
26
|
5.5
|
Homograft
|
15
|
1
|
6.7
|
Total
|
6,217
|
266
|
4.3
|
Note: Transcatheter procedures are excluded.
Table V5
Multiple heart valve procedures
Combination
|
N
|
†
|
%
|
Mitral + tricuspid
|
1,665
|
142
|
8.5
|
Aortic + mitral
|
1,401
|
157
|
11.2
|
Aortic + mitral + tricuspid
|
407
|
58
|
14.3
|
Aortic + tricuspid
|
160
|
24
|
15.0
|
Aortic + pulmonary[a]
|
54
|
0
|
0.0
|
Tricuspid + pulmonary
|
18
|
0
|
0.0
|
Aortic + mitral + pulmonary
|
2
|
1
|
50.0
|
Total
|
3,707
|
382
|
10.3
|
Note: Transcatheter procedures excluded.
a Including Ross procedures.
Table V6
Isolated/combined mitral valve surgery—implantation/replacement versus repair
Mitral valve surgery
|
Repair
|
Implantation/replacement
|
All procedures
|
N
|
†
|
%
|
N
|
†
|
%
|
N
|
% repair
|
†
|
%
|
Isolated
|
3,908
|
49
|
1.3
|
2,309
|
217
|
9.4
|
6,217
|
62,9
|
266
|
4.3
|
+ Aortic valve
|
563
|
42
|
7.5
|
838
|
115
|
13.7
|
1,401
|
40,2
|
157
|
11.2
|
+ Tricuspid valve repair[a]
|
977
|
44
|
4.5
|
631
|
86
|
13.6
|
1,608
|
60,8
|
130
|
8.1
|
+ CABG
|
1,585
|
107
|
6.8
|
976
|
157
|
16.1
|
2,561
|
61,9
|
264
|
10.3
|
+ CABG + aortic valve replacement
|
310
|
30
|
9.7
|
309
|
64
|
20.7
|
619
|
50,1
|
94
|
15.2
|
Total
|
7,343
|
272
|
3.7
|
5,063
|
639
|
12.6
|
12,406
|
59,2
|
911
|
7.3
|
a 57 procedures (not specified mitral valve + tricuspid valve surgery) were excluded;
†: 21% (12/57).
Table V7
Transcatheter heart valve procedures
|
Without ECC
|
With ECC
|
All procedures
|
N
|
†
|
N
|
†
|
N
|
†
|
%
|
Aortic valve implantation
|
10,765
|
290
|
114
|
35
|
10,879
|
325
|
3
|
Transvascular
|
8,731
|
206
|
61
|
25
|
8,792
|
231
|
3
|
Transapical
|
2,034
|
84
|
53
|
10
|
2,087
|
94
|
5
|
Mitral valve
|
770
|
31
|
27
|
6
|
797
|
37
|
5
|
Repair
|
628
|
20
|
22
|
1
|
650
|
21
|
3
|
Implantation
|
142
|
11
|
5
|
5
|
147
|
16
|
11
|
Tricuspid valve repair
|
24
|
1
|
1
|
0
|
25
|
1
|
4
|
Repair
|
22
|
1
|
1
|
0
|
23
|
1
|
4
|
Implantation
|
2
|
0
|
0
|
0
|
2
|
0
|
0
|
Aortic + mitral valve implantation
|
15
|
2
|
0
|
0
|
15
|
2
|
13
|
Aortic valve implantation[a] + CABG
|
33
|
4
|
16
|
6
|
49
|
10
|
20
|
Mitral valve implantation[b] + CABG
|
0
|
0
|
3
|
1
|
3
|
1
|
33
|
Aortic + mitral valve + CABG
|
0
|
0
|
0
|
0
|
0
|
0
|
−
|
Total
|
11,607
|
328
|
161
|
48
|
11,768
|
376
|
3
|
Abbreviations: CABG, coronary artery bypass grafting; ECC, extracorporeal circulation.
Notes: Pulmonary valve implantation for the correction of congenital lesions is not included,
No procedure was reported for adults without congenital lesion, 19% of transcatheter
aortic valve implantation (TAVI) by transapical access; and 1% of TAVI under use of
ECC.
a Femoral, subclavian, or transaortic access.
b Transvascular and transapical access.
Table C1
Isolated CABG and combined procedures with ECC
Procedures
|
N
|
†
|
%
|
Isolated CABG
|
37,614
|
1,080
|
2.9
|
+ aortic valve replacement
|
6,742
|
321
|
4.8
|
+ other
|
2,401
|
154
|
6.4
|
+ mitral valve repair
|
1,585
|
107
|
6.8
|
+ mitral valve replacement
|
976
|
157
|
16.1
|
+ aortic valve replacement + mitral valve repair
|
310
|
30
|
9.7
|
+ aortic + mitral valve replacement
|
309
|
64
|
20.7
|
+ aneurysm resection
|
125
|
9
|
7.2
|
+ transcatheter aortic valve implantation
|
49
|
10
|
20.4
|
Total
|
50,111
|
1,932
|
3.9
|
Abbreviations: CABG, coronary artery bypass grafting; ECC, extracorporeal circulation.
Table C2
Isolated CABG with/without ECC
Grafts (n)
|
With ECC
|
Without ECC
|
All
|
N
|
†
|
%
|
N
|
†
|
%
|
N
|
†
|
%
|
Single
|
1,013
|
59
|
5.8
|
1,488
|
45
|
3.0
|
2,501
|
104
|
4.2
|
Double
|
6,604
|
247
|
3.7
|
1,941
|
36
|
1.9
|
8,545
|
283
|
3.3
|
Triple
|
13,524
|
405
|
3.0
|
2,361
|
35
|
1.5
|
15,885
|
440
|
2.8
|
Quadruple
|
7,261
|
178
|
2.5
|
961
|
15
|
1.6
|
8,222
|
193
|
2.3
|
Quintuple + more
|
2,254
|
59
|
2.6
|
207
|
1
|
0.5
|
2,461
|
60
|
2.4
|
Total
|
30,656
|
948
|
3.1
|
6,958
|
132
|
1.9
|
37,614
|
1,080
|
2.9
|
Abbreviations: CABG, coronary artery bypass grafting; ECC, extracorporeal circulation.
Table Con1
Congenital heart surgery with/without ECC
Age (y)
|
N
|
†
|
%
|
With ECC
|
Without ECC
|
With ECC
|
Without ECC
|
With ECC
|
Without ECC
|
< 1
|
2,154
|
835
|
80
|
25
|
3.7
|
3.0
|
1–17
|
1,672
|
238
|
18
|
3
|
1.1
|
1.3
|
≥ 18
|
1,001
|
20
|
33
|
1
|
3.3
|
5.0
|
Total
|
2,673
|
258
|
51
|
4
|
1.9
|
1.6
|
Abbreviation: ECC, extracorporeal circulation.
Table Con2
Procedures for congenital heart disease with and without ECC
Lesion/procedure
|
Age < 1 y
|
Age 1–17 y
|
Age ≥ 18 y
|
N
|
†
|
%
|
N
|
†
|
%
|
N
|
†
|
%
|
ASD
|
35
|
0
|
0.0
|
245
|
0
|
0.0
|
272
|
4
|
1.5
|
Complete AV canal
|
213
|
5
|
2.3
|
75
|
1
|
1.3
|
13
|
0
|
0.0
|
VSD
|
295
|
0
|
0.0
|
110
|
0
|
0.0
|
20
|
0
|
0.0
|
Fallot's tetralogy
|
188
|
3
|
1.6
|
52
|
0
|
0.0
|
5
|
0
|
0.0
|
DORV
|
56
|
2
|
3.6
|
15
|
0
|
0.0
|
1
|
0
|
0.0
|
TGA
|
171
|
1
|
0.6
|
3
|
0
|
0.0
|
0
|
0
|
–
|
TGA + VSD
|
54
|
3
|
5.6
|
5
|
0
|
0.0
|
0
|
0
|
–
|
Truncus arteriosus
|
35
|
2
|
5.7
|
8
|
0
|
0.0
|
1
|
0
|
0.0
|
Fontan
|
2
|
0
|
0.0
|
214
|
1
|
0.5
|
8
|
1
|
12.5
|
Norwood
|
183
|
30
|
16.4
|
2
|
1
|
50.0
|
0
|
0
|
–
|
Pulmonary valve
|
64
|
1
|
1.6
|
199
|
2
|
1.0
|
71
|
4
|
5.6
|
Transcatheter pulmonary valve implantation
|
0
|
–
|
–
|
6
|
0
|
0.0
|
3
|
0
|
0.0
|
Aortic valve
|
50
|
1
|
2.0
|
188
|
5
|
2.7
|
347
|
8
|
2.3
|
Ross procedure
|
9
|
0
|
0.0
|
29
|
0
|
0.0
|
29
|
0
|
0.0
|
Mitral valve
|
35
|
1
|
2.9
|
100
|
0
|
0.0
|
86
|
9
|
10.5
|
Tricuspid valve
|
68
|
3
|
4.4
|
58
|
2
|
3.4
|
45
|
3
|
6.7
|
PDA
|
214
|
8
|
3.7
|
28
|
0
|
0.0
|
1
|
0
|
0.0
|
Coarctation
|
208
|
1
|
0.5
|
38
|
0
|
0.0
|
3
|
0
|
0.0
|
Others
|
1,105
|
44
|
4.0
|
481
|
7
|
1.5
|
116
|
5
|
4.3
|
HTx
|
4
|
0
|
0.0
|
38
|
1
|
2.6
|
0
|
0
|
–
|
HLTx
|
0
|
–
|
–
|
2
|
0
|
0.0
|
0
|
0
|
–
|
LTx
|
0
|
–
|
–
|
14
|
1
|
7.1
|
0
|
0
|
–
|
Total
|
2,989
|
105
|
3.5
|
1,910
|
21
|
1.1
|
1,021
|
34
|
3.3
|
Abbreviations: ASD, atrial septal defect; AV, atrioventricular; DORV, double outlet
right ventricle; ECC, extracorporeal circulation; HLTx, heart–lung transplantation;
HTx, heart transplantation; LTx, lung transplantation; PDA, patent ductus arteriosus;
TGA, transposition of the great arteries; VSD, ventricular septal defect.
Table Mis1
Ross procedures (autologous aortic and pulmonary valve replacement)
Age (y)
|
2007
|
2008
|
2009
|
2010
|
2011
|
2012
|
2013
|
2014
|
2015
|
2016
|
< 18
|
34
|
42
|
54
|
43
|
40
|
36
|
33
|
37
|
28
|
38
|
≥ 18
|
261
|
207
|
175
|
184
|
134
|
117
|
107
|
90
|
64
|
72
|
Total
|
295
|
249
|
229
|
227
|
174
|
153
|
140
|
127
|
92
|
110
|
Abbreviation: AV, aortic valve.
Table Mis2
Heart and lung transplantation
Organ
|
With ECC
|
Without ECC
|
N
|
†
|
%
|
N
|
†
|
%
|
HTx
|
291
|
38
|
13.1
|
|
|
|
HLTx
|
7
|
0
|
0.0
|
|
|
|
LTx
|
53
|
10
|
18.9
|
247
|
14
|
5.7
|
Abbreviations: HTx, heart transplantation; HLTx, heart–lung transplantation; LTx,
lung transplantation; Tx, transplantation.
Notes: All pediatric transplantations (demonstrated in [Table Con2]) are included in this table, Eurotransplant report 2016: 287 HTx, 2 HTx + kidneyTx,
1 HTx + liverTx, 7 HLTx, 281 double lung transplantation, 38 single lung transplantation,
0 LTx + kidneyTx, and 2 LTx + liverTx.
Table Mis3
Aortic surgery
Replacement[a]
|
With ECC
|
Without ECC
|
N
|
†
|
%
|
N
|
†
|
%
|
Supracoronary replacement of ascending aorta
|
1,383
|
128
|
9.3
|
|
|
|
Supracoronary ascending + aortic valve replacement
|
1,325
|
69
|
5.2
|
|
|
|
Infracoronary ascending
|
Mechanical valve conduits
|
441
|
33
|
7.5
|
|
|
|
Biological valve conduits
|
999
|
110
|
11.0
|
|
|
|
David procedure
|
537
|
15
|
2.8
|
|
|
|
Yacoub procedure
|
120
|
5
|
4.2
|
|
|
|
Other
|
286
|
21
|
7.3
|
|
|
|
Aortic arch replacement[b]
|
2,117
|
246
|
11.6
|
|
|
|
Replacement of descending aorta
|
43
|
20
|
46.5
|
7
|
1
|
14.3
|
Thoracoabdominal aortic replacement
|
101
|
16
|
15.8
|
24
|
5
|
20.8
|
Endostent descending aorta
|
17
|
0
|
0.0
|
719
|
46
|
6.4
|
Total
|
7,369
|
663
|
9.0
|
750
|
52
|
6.9
|
Abbreviation: ECC, extracorporeal circulation.
Notes: All procedures involving aortic surgery are included in this table, isolated aortic
surgery as well as all possible combined procedures (e.g., additional coronary artery
bypass grafting) are summarized in this category.
a Procedures for abdominal aortic diseases excluded: 449 abdominal procedures and 734
endovascular abdominal stents.
b All possible combined procedures included, the only common denominator is aortic
arch surgery.
Table Mis4
Pacemaker and ICD procedures
Device/category
|
|
With ECC
|
Without ECC
|
N
|
†
|
%
|
N
|
†
|
N
|
†
|
Pacemaker
|
13,882
|
118
|
0.9
|
25
|
4
|
13,857
|
114
|
Implantation
|
8,968
|
71
|
0.8
|
8
|
1
|
8,960
|
70
|
Battery exchange
|
1,907
|
2
|
0.1
|
2
|
0
|
1,905
|
2
|
Revision procedures
|
3,007
|
45
|
1.5
|
15
|
3
|
2,992
|
42
|
ICD
|
9,368
|
85
|
0.9
|
17
|
2
|
9,351
|
83
|
Implantation
|
4,140
|
21
|
0.5
|
2
|
1
|
4,138
|
20
|
Battery exchange
|
2,019
|
3
|
0.1
|
0
|
0
|
2,019
|
3
|
Revision procedures
|
3,209
|
61
|
1.9
|
15
|
1
|
3,194
|
60
|
Miscellaneous
|
1,430
|
11
|
0.8
|
0
|
0
|
1,430
|
11
|
Total
|
24,680
|
214
|
0.9
|
42
|
6
|
24,638
|
208
|
Abbreviations: ECC, extracorporeal circulation; ICD, implantable cardioverter defibrillator.
Table Mis5
Surgical ablation procedures for tachyarrhythmia
Energy source
|
Total
|
Endocardiac
|
Epicardiac
|
N
|
N
|
Unipolar radiofrequency
|
200
|
65
|
135
|
Unipolar cryo-radiofrequency
|
241
|
109
|
132
|
Bipolar radiofrequency
|
2,210
|
223
|
1,987
|
Cryothermy
|
1,523
|
1,307
|
216
|
Microwave
|
13
|
3
|
10
|
Focused ultrasound
|
89
|
22
|
67
|
Laser
|
0
|
0
|
0
|
Other
|
29
|
14
|
15
|
Total
|
4,305
|
1,743
|
2,562
|
Note: 419 procedures are not specified with regard to endocardiac/epicardiac ablation.
Fig. 1 Selected heart surgical categories (2007–2016). (1) CABG and combined procedures:
all types of coronary surgery. (2) Heart valve procedures: combination with aortic
surgery summarized under miscellaneous procedures. (3) Congenital heart surgery: ASD
repairs in adults or in combination with CABG or heart valve procedures are summarized
in the CABG or heart valve procedure groups. (4) Miscellaneous procedures: all other
types of procedures with ECC. ASD, atrial septal defect; CABG, coronary artery bypass
grafting; ECC, extracorporeal circulation.
Fig. 2 Unadjusted mortality for selected procedures (2007–2016). AV, aortic valve; CABG,
coronary artery bypass grafting; MV, mitral valve; TAVI, transcatheter heart valve
intervention.
Fig. 3 Isolated coronary artery bypass grafting (2007–2016).
Fig. 4 Isolated aortic valve replacement (2007–2016). Notes: Ross procedures, homograft implantations, and transcatheter heart valve intervention
excluded.
Fig. 5 Isolated aortic valve replacement and transcatheter aortic valve implantation (TAVI)
The annual count of TAVI submitted to the voluntary registry of German Society for
Thoracic and Cardiovascular Surgery does not represent all TAVI procedures performed
in Germany in 2016. +Additional TAVI procedures calculated from the German legal quality assurance program,
§ 137 SGB V.
Fig. 6 Age distribution of cardiac procedures (2007–2016). Notes: Patients < 20 years and pacemaker/implantable cardioverter defibrillator procedures
were excluded.
Fig. 7 Urgency categories (2007 vs. 2016) Emergency = acutely life-threatening cardiac/vascular
disease.
Fig. 8 Isolated mitral valve surgery (2007–2016).
Fig. 9 Age distribution for CHD (2007–2016). Notes: Bias possible due to the fact that not all relevant procedures can be allocated
exactly to CHD category in patients older than 18 years (e.g., aortic valve disease).
CHD, congenital heart disease.
Compared with the data of previous years, several important developments continued
in 2016 almost unchanged. The age distribution of patients ([Fig. 6]) shows a continuous shift to an elderly patient population with presently 52.8%
of the cardiac procedures performed in patients of at least 70 years of age and 15.7%
in octogenarians. However, mortality remained on the same low level over the represented
decade ([Fig. 2]). In this context it has to be noted that all designated mortality rates of this
registry are unadjusted values. This must be taken into account for any interpretation.
The rate of CABG procedures decreased over the past decade, while the relative number
for off-pump CABG now reached a level of 18.5% (2015: 16.5%) ([Fig. 3]).
A still ongoing trend is the increase of TAVI procedures in Germany ([Fig. 5], [Table V7]), while the count of isolated aortic valve replacement procedures remained on a
comparable level with just a slight decrease of 2.0%. Starting in 2006 with just 78
implantations (0.67% of isolated aortic valve procedures), in 2016 a total of 10,879
(49.8%) TAVIs was reported to the registry. It must be emphasized that the 78 institutions
which contribute their data to this registry do not represent all departments performing
TAVI in Germany. In each case, the proceeding must correlate to the recommendations
of international guidelines.[28]
[29]
[30] For the German health service, a quality assurance directive for “minimally invasive
heart valve interventions (TAVI, mitral valve clip reconstruction)” came into effect
by law in July 2015, in which obligatory structures, defined processes, and qualified
personnel are precisely specified. In addition to this registry responding to the
directive of the Federal Joint Committee (G-BA), the results of the voluntary German
Aortic Valve Registry[31]
[32]
[33]
[34]
[35]
[36]
[37]
[38] as well as the annual analyses for selected procedures in the context of the legally
compulsory quality assurance (§137 SGB V) contribute to an exceptional patient benefit.
Since 2004, more than 50% of isolated mitral valve procedures have been reconstructions.
In 2016, a mitral valve reconstruction could be achieved in 62.9% of the procedures
([Fig. 8]). Based on the fact that all isolated mitral valve procedures are included without
exception, regardless of the underlying valve disease concerning morphology or urgency
of operation, it has to be assumed that the relative rate of mitral valve reconstruction
would certainly be even higher if patients without possibility or indication for reconstruction
would have been excluded (e.g., mitral valve stenosis, calcifications, or endocarditis).
In other publications, for example, Gammie et al,[39] patients with mitral valve stenosis, endocarditis, and emergency procedures are
usually excluded. Therefore, the published rates of mitral valve repair have to be
interpreted with caution if compared with this registry.
The continued increase of left ventricular assist device implantations ([Fig. 10]) emphasizes the importance of mechanical circulatory support therapies, while biventricular
assist device and total artificial heart implantations are of subordinate importance
with only 3.6%.
Fig. 10 Development of mechanical circulatory support (2007–2016). BVAD, biventricular assist
device; LVAD, left ventricular assist device; TAH, total artificial heart.
Discussion
The registry of the GSTCVS enables a comprehensive overview of all heart surgical
procedures performed in Germany in 2016. The accuracy of this registry is considered
to be high due to the implemented compilation algorithm using standardized operation
coding which is a relevant criterion for reimbursement purposes. This is supported
by other authors who could demonstrate a high accuracy for major outcome parameters
in unaudited registries.[40] In continuation with previous years, it can be concluded that heart surgery in Germany
is performed on a constantly high level with superior in-hospital patient survival
rates compared with international registries. In addition, the registry demonstrates
that the German heart surgical provision is appropriate and the treatment of patients
is guaranteed nationwide at any time (24/7/365). These aspects are especially important
in the context of various activities in health care policy and the demographic change
of the German population leading to an increase of patient age and related comorbidities
and resulting in higher preoperative risk profile.
Compared with 2015, the number of cardiac surgery procedures remains on nearly the
same level, due to the continuous increase of catheter-based heart valve procedures.
Further improvements in the basic configuration of the registry are recommended to
enable more detailed and particularly risk-adjusted data analyses. However, if significant
structural changes of data collection for the registry are conducted, it must be ensured
that data compatibility still allows further longitudinal data analysis.
Completeness, validity, and further developments will depend on continued efforts
of the GSTCVS in close collaboration with all cardiac surgical departments in Germany.
This will be of outstanding importance in the sense of a contribution for patient
safety and to obtain evidence for the high quality of heart surgery in Germany.